These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24346851)

  • 1. Gender differences in pharmacokinetics of a combination tablet of niacin extended-release/simvastatin in healthy Chinese volunteers.
    Wang XL; Liu M; Yang M; Zhang YN; Zhang D; Zhang LN; Han J; Liu HC
    Eur J Drug Metab Pharmacokinet; 2014 Dec; 39(4):321-6. PubMed ID: 24346851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of niacin, simvastatin and their metabolites in healthy Chinese subjects after single and multiple doses of a fixed dose combination tablet of niacin extended release/simvastatin.
    Liu M; Wang XL; Zhang D; Yang M; Han J; Zhang YN; Wang ZL; Liu HC
    Drug Res (Stuttg); 2014 Jun; 64(6):296-300. PubMed ID: 24154936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects.
    Kosoglou T; Zhu Y; Statkevich P; Triantafyllou I; Taggart W; Xuan F; Kim KT; Cutler DL
    Eur J Clin Pharmacol; 2011 May; 67(5):483-92. PubMed ID: 21120461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of ezetimibe/simvastatin combination tablet: an open-label, single-dose study in healthy Chinese subjects.
    Chu NN; Chen WL; Xu HR; Li XN
    Clin Drug Investig; 2012 Dec; 32(12):791-8. PubMed ID: 23109219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects.
    Lauring B; Dishy V; De Kam PJ; Crumley T; Wenning L; Liu F; Sisk C; Wagner J; Lai E
    Am J Ther; 2015; 22(5):367-76. PubMed ID: 24832384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
    Menon R; Tolbert D; Cefali E
    Biopharm Drug Dispos; 2007 Sep; 28(6):297-306. PubMed ID: 17571283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
    Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome.
    Fazio S; Guyton JR; Lin J; Tomassini JE; Shah A; Tershakovec AM
    Diabetes Obes Metab; 2010 Nov; 12(11):983-93. PubMed ID: 20880345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders.
    Vo AN; Kashyap ML
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1303-10. PubMed ID: 19018682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects.
    Migoya EM; Bergman A; Hreniuk D; Matthews N; Yi B; Roadcap B; Valesky R; Liu L; Riffel K; Groff M; Zhao JJ; Musson DG; Gambale J; Kosoglou T; Statkevich P; Lasseter KC; Laurent A; Johnson-Levonas AO; Murphy G; Gottesdiener K; Paolini JF
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):83-92. PubMed ID: 16502768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
    Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin extended release (ER)/simvastatin (Simcor®): a guide to its use in lipid regulation.
    Lyseng-Williamson KA
    Drugs R D; 2010; 10(4):253-60. PubMed ID: 21171671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of simvastatin lactone and its active metabolite simvastatin hydroxy acid in healthy Chinese male and female volunteers.
    Yang W; Xu H; Song Y; Wang X; Ren X; Zhao D; Cai Y; Zhang S; Huang J; Zhang LR; Zhang T; Zuo M
    Int J Clin Pharmacol Ther; 2014 Feb; 52(2):151-8. PubMed ID: 24290412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of two formulations of simvastatin tablets in healthy Thai volunteers.
    Lohitnavy M; Lohitnavy O; Chaijittiprasert K; Taytiwat P; Polnok S
    Arzneimittelforschung; 2004; 54(1):31-4. PubMed ID: 14979606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
    Ballantyne CM; Davidson MH; McKenney J; Keller LH; Bajorunas DR; Karas RH
    Am J Cardiol; 2008 May; 101(10):1428-36. PubMed ID: 18471454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niacin extended-release/simvastatin.
    Sanford M; Curran MP
    Drugs; 2008; 68(16):2373-86. PubMed ID: 18973399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the pharmacokinetics of two different formulations of extended-release niacin.
    Lauring B; Rosko K; Luo WL; Wenning L; Kissling J; Roupe K; Paolini JF; Wagner J; Lai E
    Curr Med Res Opin; 2009 Jan; 25(1):15-22. PubMed ID: 19210135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Niacin and Its Metabolite Nicotinuric Acid in Human Plasma by LC-MS/MS: Application to a Clinical Trial of a Fixed Dose Combination Tablet of Niacin Extended-Release/Simvastatin (500 mg/10 mg) in Healthy Chinese Volunteers.
    Zhang P; Sun Y; Shi G; Sui Y; Li Q; Tang Y; Gu J
    Int J Anal Chem; 2015; 2015():212437. PubMed ID: 26345166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.